July 10, 2025- OraSure Technologies, Inc. announced the launch of its HEMAcollect™ PROTEIN product to meet the evolving needs of proteomic researchers. The product, developed by OTI subsidiary DNA Genotek, is an evacuated blood collection tube (BCT) designed to preserve and stabilize plasma proteins in whole blood for up to seven days.* Currently available for research use only**, the collection tube with its proprietary stabilizing liquid preserves plasma proteins, facilitating storage and transport of blood samples at ambient temperature, which are limitations of general blood collection tubes. It is anticipated that the use of the product for sample collection will deliver operational and financial efficiencies to proteomic researchers and support the generation of high-quality data.
“The HEMAcollect™ PROTEIN BCT represents a significant advancement in sample collection for proteomics, providing researchers with a reliable solution that preserves sample integrity and improves preanalytical workflows,” said Carrie Eglinton Manner, President and CEO of OTI. “We’re dedicated to enhancing the quality of insights for researchers through our innovative sample management solutions. The launch of this solution for blood proteomics applications is a clear reflection of that commitment and enables research applications in oncology, neurology, cardiology, metabolic disorders, and beyond.”